Skip to main content
. 2015 Dec 30;90(2):741–752. doi: 10.1128/JVI.02482-15

TABLE 2.

Characterization of recombinant viruses with secondary-site mutations

Recombinant virus Mean titer
(PFU/ml) ± SDa
IFAb
WT (2.9 ± 1.1) × 106 +++
R3A+M63L (6.0 ± 2.1) × 105 +++
R38A+D40V (1.1 ± 0.5) × 106 +++
K242A+E92G (2.3 ± 0.07) × 104 ++
K242A+T100K (1.5 ± 0.2) × 105 +++
K242A+E92G+T100K (3.9 ± 0.4) × 105 +++
K244A+Q145K ND +
K244A+T237N (2.5 ± 0.4) × 105 +++
K244A+Q145K+T237N (5.0 ± 0.7) × 106 +++
R250A+T41I ND +
R250A+E167K (4.8 ± 1.1) × 102 +
R250A+T41I+E167K 100 ± 70* +
K274A+I111L (6.0 ± 0.7) × 104 ++
K274A+A224V (4.5 ± 1.4) × 103 ++
K274A+I111L+A224V (3.0 ± 0.3) × 105 +++
a

The mean virus titers at 48 h p.t. were determined by plaque assay from three independent experiments. An asterisk represents the virus titer at 24 h p.t because the titers at 48 h p.t. and 72 h p.t. were below the limit of detection. ND, not detected.

b

IFA was repeated at least three times, and the positive rate was calculated from five random views under a microscope using Image-Pro Plus software. The positive rate for the WT was set as strong (+++) and mutant levels as strong (+++) (IFA positive rate ≥66.7% of that of the WT), ++ (medium) (IFA positive rate between 33.3% and 66.7% of that of the WT), + (weak) (IFA positive rate between 5% and 33.3% of that of the WT), and negative (−) (IFA positive rate less than 5% of that of the WT).